0001209191-21-014967.txt : 20210226
0001209191-21-014967.hdr.sgml : 20210226
20210226182748
ACCESSION NUMBER: 0001209191-21-014967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gupta Suneel
CENTRAL INDEX KEY: 0001763923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 21692435
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-26
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001763923
Gupta Suneel
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560
0
1
0
0
Chief Development Officer
Common Stock
2021-02-26
4
A
0
12000
0.00
A
63987
D
Stock Option (right to buy)
23.57
2021-02-26
4
A
0
80000
0.00
A
2031-02-25
Common
80000
80000
D
Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024.
Includes an aggregate of 2,487 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2020 and September 9, 2020.
The stock option vests in 48 equal monthly installments following the date of grant.
/s/ Donald A. Kalkofen, Attorney-in-Fact for Suneel Gupta
2021-02-26